When was Focal Therapeutics founded?

Focal Therapeutics was founded in 2007 and raised its 1st funding round 6 years after it was founded.

Where is Focal Therapeutics located?

Focal Therapeutics is headquartered in Aliso Viejo, United States.

How many employees does Focal Therapeutics have?

As of May 31, 2026, the latest employee count at Focal Therapeutics is 7.

Is Focal Therapeutics a funded company?

Focal Therapeutics is a funded company, having raised a total of $11.7M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 03, 2013.

When was the latest funding round of Focal Therapeutics?

Focal Therapeutics' latest funding was a $***** Series A round on Jan 23, 2017, with participation from 0 investor. Its primary sector is Oncology. In United States, the Oncology sector has seen $2.52B in funding in 2026 to date.

Where does Focal Therapeutics rank among its competitors?

Focal Therapeutics ranks 8th amongst 26 active competitors, of which 12 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Averto Medical, which secured $1.77M in Sep, 2025.

Who are the top competitors of Focal Therapeutics?

Focal Therapeutics' top competitors include Lumicell Diagnostics, Averto Medical and Lindis Blood Care. Among them, Averto Medical secured the most recent funding round in September, 2025.

Focal Therapeutics - 2026 Company Profile, Funding & Competitors

Q: Is Focal Therapeutics an acquired company?

Focal Therapeutics got acquired by Hologic on Sep 26, 2018.

Company Details

Women's health and diagnostics solutions, advancing well-being globally. The organization focuses on women's health products and lab technologies. It offers a range of solutions in breast health, gynecological health, sexual health, body composition, and skeletal health. In lab technologies, it provides tests, cytology, molecular diagnostics, collection devices, and screening technologies. The company is committed to global access initiatives, philanthropy, and project health equity. They provide support through safety data sheets, package inserts, medical education, and coordinated vulnerability disclosure. The organization emphasizes research and development, innovation, and patient care. They are dedicated to improving women's health through advanced medical technologies and comprehensive healthcare solutions. The company also focuses on virology highlights and well woman locations.

Website: focalrx.com
Email ID: *****@focalrx.com

Key Metrics

Founded Year

2007

Location

Aliso Viejo, United States

Stage

Acquired

Total Funding

$11.7M in 3 rounds

Latest Funding Round

Series A, Jan 23, 2017, $*****

Investors

Emergent Medical Partners & 1 more

Ranked

8^th among 26 active competitors

Employee Count

7 as on May 31, 2026

Similar Companies

Lumicell Diagnostics & 30 more

Exit Details

Acquired by Hologic (Sep 26, 2018)

View Focal Therapeutics' full profile

Focal Therapeutics got acquired by Hologic on Sep 26, 2018 at an acquisition amount of $*****.

Click here to take a look at Focal Therapeutics's acquisition in detail

Focal Therapeutics has raised a total funding of $11.7M over 3 rounds. Its first funding round was on Sep 03, 2013. Focal Therapeutics has 2 institutional investors.

Here is the list of recent funding rounds of Focal Therapeutics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 23, 2017	4192131	Series A	7268292	2414868	4969211	4134281
Mar 14, 2016	4293066	Series A	9331737	9087320	9434672	8952956
Sep 03, 2013	5407949	Series A	8239185	7426728	5144128	Emergent Medical Partners & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Focal Therapeutics's funding rounds and investors

Focal Therapeutics' employee count trend

Focal Therapeutics has 7 employees as of May 26. Here is Focal Therapeutics's employee count trend over the years:

Employee count trend for Focal Therapeutics

Uncover Focal Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Focal Therapeutics include Lumicell Diagnostics, Averto Medical and Lindis Blood Care. Here is the list of Top 10 competitors of Focal Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Lumicell Diagnostics 2008, Wellesley (United States), Series D	Developer of fluorescence-guided imaging technologies to help surgeons detect residual cancer tissue during operations	$361M	BlueIO, LaunchCapital & 8 others	63/100
2nd	Averto Medical 2016, Fremont (United States), Series A	Developer of medical devices for patients suffering from gastrointestinal diseases	$33M	Cormorant Asset Management, LifeSci Venture Partners ... & 5 others	58/100
3rd	Lindis Blood Care 2006, Hennigsdorf (Germany), Series B	Developer of a medical device to remove cancer cells from salvaged blood	$1.89M	Brandenburg Capital, HTGF & 6 others	49/100
4th	Huake Precision (Beijing) Medical Technology 2003, Beijing (China), Series D	Provider of a neurosurgery robot for neurological treatments	$13.9M	China Growth Capital, Medtronic & 11 others	47/100
5th	CytoVeris 2018, Farmington (United States), Series A	Developer of optical based guided surgical tools for cancer surgery	$3.73M	Connecticut Innovations, NIH & 2 others	36/100
6th	Fluoptics 2009, Grenoble (France), Acquired	Provider of surgery therapy solutions for professionals	$3.7M	Supernova Invest, UI Investissement & 3 others	35/100
7th	US Medical Innovations 2010, Takoma Park (United States), Series A	Developer of electrosurgery and plasma technology for the treatment of cancer	$11.2M	CB3 Holdings, Aiglon Capital Management	35/100
8th	Focal Therapeutics 2007, Aliso Viejo (United States), Acquired	Women's health and diagnostics solutions, advancing well-being globally	$11.7M	Emergent Medical Partners, Okapi Venture Capital	34/100
9th	Micropos 2003, Gothenburg (Sweden), Funding Raised	Electromagnetic positioning system for Prostrate tracking during radiotherapy	-	Chalmers Ventures	34/100
10th	Olfactomics 2015, Tampere (Finland), Seed	Developer of technology for surgical tissue assessment	-	MedTech Innovator, EIC Fund & 2 others	34/100